Small extracellular vesicles promote cell survival and neuritogenesis in vitro in a manner dependent on dosage and cell of origin

Matyas Kutnyanszky, Phil Stephens, Ben Mead · 2026

Read Small extracellular vesicles promote cell survival and neuritogenesis in vitro in a manner dependent on dosage and cell of origin by Matyas Kutnyanszky, Phil Stephens, Ben Mead (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13473494.txt.

Description

Matyas Kutnyanszky and two colleagues compared in 2026 vesicles from six cell types as a cell-free way to protect retinal neurons. Mesenchymal stem cells release protective molecules, and their small extracellular vesicles, lipid parcels under 220 nanometres, have drawn interest for safety and ease. In glaucoma, retinal ganglion cells, whose fibres form the optic nerve, die slowly, so preserving them could slow loss. The right vesicle source matters because cargo varies with donor type, age, and environment.

In a rodent laboratory model of retinal ganglion cell degeneration, adipose-derived stem cell vesicles proved most potent, with bone marrow vesicles a close second. Vesicles from umbilical cord, dental pulp, dermal fibroblasts, and oral mucosal progenitor cells showed no benefit. Both protection and new nerve growth depended on dose and cell of origin. The study guides future cell-free therapy design, while remaining a laboratory comparison needing animal and human testing.

Catalog record

CREATORMatyas Kutnyanszky, Phil Stephens, Ben Mead
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13473494

Browse the full library · About the Tower of Babel